Literature DB >> 23411704

Pneumonitis induced by rifampicin: a case report and literature review.

Yasuko Koma1, Keiko Goto, Chihiro Yoshida, Kengo Kimura, Yusuke Matsumoto, Midori Koyama, Nariyasu Nakashima, Daiki Masuya, Hirofumi Matsuoka, Harukazu Yoshimatsu, Yujiro Suzuki.   

Abstract

An 84-year-old woman being treated for miliary tuberculosis (TB) with rifampicin (RFP), isoniazid (INH), ethambutol (EB) and corticosteroids suffered from a persistent fever for five months. While tapering the dose of prednisolone, chest computed tomography (CT) revealed diffuse ground glass opacities (GGO) and bronchoalveolar lavage fluid (BALF) showed an increase in lymphocytes. After the anti-TB drugs were discontinued and the dose of the corticosteroids was increased, the CT findings and fever improved considerably. However, readministration of RFP provoked an inflammatory reaction, leading to a diagnosis of RFP-induced pneumonitis. This condition is very rare. This is the first report of RFP-induced pneumonitis occurring during adjunct steroid therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23411704     DOI: 10.2169/internalmedicine.52.8997

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

Review 1.  Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports.

Authors:  Lisa Brockhaus; Yasmin Schmid; Anna C Rast; Alexandra E Rätz Bravo; Kathrin Scherer Hofmeier; Anne B Leuppi-Taegtmeyer
Journal:  BMC Pharmacol Toxicol       Date:  2019-02-12       Impact factor: 2.483

2.  Rifampicin-Induced Pneumonitis Mimicking Severe COVID-19 Pneumonia Infection.

Authors:  Fateen Ata; Mousa Shaher Mousa Hussein; Ahmad Y Mismar; Rohit Sharma; Issam A M Bozom; Zeinab Alsiddig Ali Ibrahim; Wanis H Ibrahim
Journal:  Am J Case Rep       Date:  2020-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.